International Psoriasis Council

Advancing Knowledge. Improving Care.

World Psoriasis Day 2023: Empowering Access to Timely Treatment and Universal Healthcare from Psoriasis Advocates Worldwide

World Psoriasis Day serves as a reminder of the critical need for accessible and timely treatment for those affected by this often misunderstood disease. As the International Psoriasis Council (IPC) reiterates its commitment to access to care for all, the importance of universal healthcare takes center stage in the battle against psoriasis. Within our global network, dedicated advocates are tirelessly working to bridge the gap and ensure that everyone has equal access to comprehensive and timely care regardless of their background.

1. What does the right treatment at the right time mean to you?

Understanding the disease from the patient's perspective and a patient-centric approach is key when selecting the optimal treatment for each patient. We, as dermatologists, want an effective, safe, and long-lasting treatment. On the other hand, patient convenience and patients’ preference for an oral or injectable medication are important considerations to be taken into account. Maria-Angeliki Gkini, MD, MSc, PhD | United Kingdom 2023 IPC Fellow
In my opinion, receiving the right treatment at the right time can minimize the pain caused by psoriasis, enhance patients' confidence in treatment, and prevent the progression of the disease and the occurrence of comorbidities. Xuejun Zhang, MD, PhD | China IPC Councilor

2. What does universal healthcare mean to your patients?

Universal healthcare would mean that my patients can access quality and affordable healthcare wherever they are without having to travel all the way to the National Hospital to access Dermatologists and drugs. Priscilla Angwenyi, MD | Kenya 2023 IPC Fellow

3. What are psoriasis advocates doing in your country to promote access for all?

Dermatologists, patient associations, and also pharma are talking to relevant actors in our Ministry of Health, senators and deputies, other doctors, and the community to teach the problems of psoriasis and its possible solutions and raise awareness about the need for help. Fernando Valenzuela, MD | Chile IPC Councilor

Please take a moment to share your insights on these vital questions in the comment section below. Your voice matters in the global dialogue on psoriasis care. Let’s continue working together for a world where accessible healthcare is a reality for all.

Comments are closed.

[searchwp_search_form engine=blog_search target="/news" var=_blog_search]

Categories

Recent Posts

Six people stand side by side in business attire, smiling at the camera. Behind them, a banner reads IPC International Council 2025 Think Tank Puerto Rico, focused on Psoriasis in Latin America, with colorful designs and sunlight filtering through curtains.

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

VIEW
A large group attends a conference session, with several panelists seated at a table onstage. One attendee stands to ask a question. The IPC (International Psoriasis Council) logo and AAD 2026 appear in the corner.

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

VIEW
A man in a suit smiles at the camera next to text that reads, World Psoriasis Experts Give Their Take on Current, Hot, or Controversial Topics like Biologics in Psoriasis Management. EXPERT COMMENTARY.

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026